Novel Multi-Payload ADCs Assembled in One Step From Native Antibodies Show High Efficacy & Tolerability In Vivo
- Presentation of AraLinQTM: the Araris conjugation technology enabling the synthesis of multi-payload ADCs in one step
- Addressing the limitations of current mono-payload ADCs by combining payloads with distinct modes of action
- Sharing examples of dual- and triple-payload ADCs prepared using the Araris technology demonstrating high efficacy and tolerability in vivo